Drug Type Small molecule drug |
Synonyms TUG-2015 |
Target |
Action modulators |
Mechanism FFAR3 modulators(free fatty acid receptor 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Diseases | Preclinical | Denmark | 06 Mar 2020 | |
Metabolic Diseases | Preclinical | Denmark | 06 Mar 2020 | |
Metabolic Diseases | Preclinical | United Kingdom | 06 Mar 2020 | |
Inflammation | Preclinical | Denmark | 06 Mar 2020 | |
Inflammation | Preclinical | Denmark | 06 Mar 2020 | |
Inflammation | Preclinical | United Kingdom | 06 Mar 2020 |